(Q84984561)
Statements
Considerations on discontinuing natalizumab for the treatment of multiple sclerosis (English)
Ralf Gold
Joseph R Berger
Giancarlo Comi
Christian Confavreux
Gavin Giovannoni
Hans-Peter Hartung
Fred Lublin
Augusto Miravalle
Paul O'Connor
Tomas Olsson
Chris H Polman
Olaf Stuve
Jerry S Wolinsky
1 September 2010